KLBF:IDX
Kalbe Farma Tbk PT
790,00 IDR
arrow_upward
+1,28%(+10,00) 1 d.
15. 10., 16:13:44 GMT+7 · IDR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre KLBF…
Otvoriť
780 IDR
Vysoká
795 IDR
Nízka
775 IDR
Trh. kap.
36,98 bil.
Priem. obj.
63,64 mil.
Objem
41,92 mil.
Dividenda
2,53 %
Štvrťročná dividenda
5 IDR
Prvý obchodný deň po vyplatení dividendy
4. 6. 2026
Pomer cena/zárobky
9,93
Max. za 52 týž.
1 345 IDR
Min. za 52 týž.
630 IDR
Výnosy na akciu
80 IDR
Akcie v obehu
46,81 mld.
Počet zamestnancov
13 tis.
Otvoriť
780 IDR
Vysoká
795 IDR
Nízka
775 IDR
Trh. kap.
36,98 bil.
Priem. obj.
63,64 mil.
Objem
41,92 mil.
Dividenda
2,53 %
Štvrťročná dividenda
5 IDR
Prvý obchodný deň po vyplatení dividendy
4. 6. 2026
Pomer cena/zárobky
9,93
Max. za 52 týž.
1 345 IDR
Min. za 52 týž.
630 IDR
Výnosy na akciu
80 IDR
Akcie v obehu
46,81 mld.
Počet zamestnancov
13 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
CNBC
·
pred 1 hodinou
Equal-weight failed. Now tech stocks look shaky again. So what should you do about S&P 500 risk?
The Seattle Times
·
pred 50 minútami
Wall Street steadies following jarring drops for AI stocks worldwide
CryptoTicker
·
pred 14 minútami
Animoca Brands: Nasdaq listing on hold, Moca Chain live
Reuters
·
pred 2 hodinami
Nasdaq reports network disruption, US equities data feeds impacted
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Informácie o subjekte Kalbe Farma Tbk PT
Generálny riaditeľ-
Zamestnanci12,8 tis.
Dátum založenia10. 9. 1966
Hlavné sídlo-
Odvetvie-
Webkalbe.co.id